The field of partial reprogramming is transitioning from successful mouse studies to its first human clinical trials. At the heart of this experiment lies the discovery of Yamanaka ...
Life Biosciences, a Boston longevity biotech co-founded by Harvard genetics professor David Sinclair, has locked down an $80 ...
Life Biosciences, Inc., (“Life Bio”) a biotechnology company pioneering cellular rejuvenation therapies to reverse and prevent multiple diseases of aging, today announced the close of a ...
Scientists at the Salk Institute for Biological Studies and Sanford Burnham Prebys explore genetic factors in separate papers ...
It is well known that students who prepare in advance perform better in exams. Now, it appears that the skin can do the same.
HexemBio emerges with a breakthrough blood stem cell rejuvenation technology led by Draper Associates and an advisory ...
AVAI, BIOA, NAGE, LLY, and NVO Lead a New Wave of Metabolic and Molecular Anti-Aging Therapies Issued on behalf of Avaí Bio, Inc. Companies mentioned in this article: Avaí Bio, Inc. (OTCQB: AVAI), ...
HexemBio has launched with a seed round led by Draper Associates to advance a blood stem cell rejuvenation therapy backed by Robert Langer.
It is well known that students who prepare in advance perform better on exams. Now, it appears that the skin can do the same.Rather than scrambling to ...
In an interview with Torbjörn Ogéus, Stockholms led- & smärtklinik (SLS), Open Access Government explores how the landscape of regenerative medicine is shifting ...
Researchers at Oregon Health & Science University have uncovered a key reason why immunotherapy has largely failed in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results